RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.
Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accu...
Main Authors: | Ken'ichiro Hayashi, Bunta Watanabe, Yoshiaki Nakagawa, Saki Minami, Tsuyoshi Morita |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3928398?pdf=render |
Similar Items
-
Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A.
by: Bunta Watanabe, et al.
Published: (2015-01-01) -
Interactive association between RhoA transcriptional signaling inhibitor, CCG1423 and human serum albumin: Biophysical and in silico studies
by: Kabir, Md Zahirul, et al.
Published: (2018) -
Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathway
by: Jessica L. Bell, et al.
Published: (2013-05-01) -
Human Ribosomal Proteins RPeL27, RPeL43, and RPeL41 Are Upregulated in Nasopharyngeal Carcinoma Cell Lines
by: Sim, E.U.H., et al.
Published: (2016) -
Strong Equivalence of TAG and CCG
by: Lena Katharina Schiffer, et al.
Published: (2021-01-01)